Xeno Transplants Corporation

OTCPK:XENO Stock Report

Market Cap: US$4.0k

Xeno Transplants Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Elliot Lebowitz

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure18.8yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure17.6yrs

Recent management updates

No updates

Recent updates

No updates


CEO

Elliot Lebowitz (82 yo)

18.8yrs

Tenure

Dr. Elliot Lebowitz, Ph.D. has been President and Chief Executive Officer of Xeno Transplants Corporation since August 2, 2006. Dr. Lebowitz also has been President and Chief Executive Officer of Xeno sinc...


Board Members

NamePositionTenureCompensationOwnership
Wayne Smith
Chief Financial Officer17.8yrsUS$20.96kno data
Elliot Lebowitz
Chief Executive Officer18.8yrsno datano data
Milton Datsopoulos
Directorno datano datano data
Michael Perry
Chairman17.5yrsno datano data
David Sachs
Director17.5yrsno datano data

17.6yrs

Average Tenure

82yo

Average Age

Experienced Board: XENO's board of directors are seasoned and experienced ( 17.6 years average tenure).